Introduction
This report analyzes the overarching clinical research organization (CRO) trends in the pharma industry, examines which regions are set to see growth in CRO activity, evaluates the leading CROs, and outlines the future of the industry. It also highlights the evolving business and relationship models between CROs and sponsor companies.
Scope of this research
* Identifies and analyses the most recent trends and issues in outsourcing clinical R&D.
* Describes where clinical trials will be conducted in the future.
* Explores the complexities and the costs of outsourcing R&D to different world regions.
* Profiles the major international CRO players.
* Provides a detailed assessment of the current CRO market, including market share information and the size/growth of R&D spending.
Research and analysis highlights
The total CRO market size is estimated at $20 billion in 2008 and expected to grow at an annual rate of 8.5% to reach $35 billion through 2015. The market is highly fragmented and the number of CROs worldwide has reached over 1,100 despite continued consolidation.
CROs provide substantial global capacity to drug developers and have become a critical contributor to clinical trial activity. Clinical trials conducted by CROs are completed up to 30% more quickly than those conducted in-house by pharma companies.
Of the large, global contract research providers, Quintiles is market leader, with 15% of the global market share, followed by Covance and PPD. The five largest CROs have increased their market share and now hold 55% of the total market.
Key reasons to purchase this research
* Save time and money in research with the report's up to date review and analysis of all the important trends in contract research.
* Develop deeper insight into the size and growth of the global CRO industry by utilizing the report's unique market forecasts.
* Assess your organization's outsourcing strategy and understand how drug development costs can be reduced in the future.
* Identify the differences between full-service and niche CROs and which capabilities best fit the needs of your organization.
* Understand the current and future contract research industry dynamics anticipate where the future CROs will be placed.